Why Herd Immunity Is Slipping Away

On Tuesday, a blowout in the New York primaries cemented Mayor Zohran Mamdani as a local kingmaker. All of his chosen candidates won, and their victories pointed to a growing movement within the Democratic Party. Nicholas Fandos, who covers New York politics for The New York Time ...  Show more

As the United States and Iran try to reach a lasting end to the war, a major hurdle has emerged: the volatile conflict in Lebanon. President Trump needs Israel to stop attacking Hezbollah there to get Iran to agree to a deal. The New York Times reporters Ronen Bergman and Mark Ma ...  Show more

Short Wave's Emily Kwong talks with NPR health correspondent Allison Aubrey about some of the latest coronavirus news, including the return of the Johnson & Johnson vaccine in the U.S. and vaccine outreach in harder to reach communities.Have questions about the latest coronavirus ...  Show more

As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ...  Show more

As Covid-19 cases continue to rise throughout the South and Southwest of the U.S., White House Task Force Member Dr. Anthony Fauci suggested the country might need to “reset.” At least 27 states have paused or rolled back their re-openings as the U.S. recently saw the highest dai ...  Show more

A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ...  Show more